PFE

$PFE

Pfizer Inc.

Global pharmaceutical company known for vaccines and oncology treatments.

Healthcare
$28.56
-0.30 (-1.04%)
Day Range$28.43 - $28.66
Prev Close$28.86

PFE key facts as of November 14, 2026

Latest AI research report
PFE Stock: Earnings, Yield and Patent Risks (as of November 14, 2026)
StockAlpha report sentiment
Neutral (as of November 14, 2026)
Analyst consensus
Hold (1 Strong Buy, 8 Buy, 17 Hold, 1 Sell, 1 Strong Sell) (as of November 1, 2026)
Analyst price target
$31.50 mean (range $27.00 to $40.00) (as of November 17, 2026)
Sector
Healthcare
Analyst Rating
Hold
9 Buy / 17 Hold / 2 Sell
Price Target
$31.50
10.3% upside
Subscribers
0
Tracking this ticker
Latest Report

Analysis from Nov 13, 2026

NEUTRAL

PFE Stock: Earnings, Yield and Patent Risks

Pfizer beat Q3 estimates and raised its 2026 revenue forecast, yet the shares remain weighed down by declining earnings trends and patent-expiration concerns. Here’s a balanced look at the dividend, valuation, analyst expectations and upcoming risks.

Nov 14, 2026

PFE FAQ

What is StockAlpha's latest view on PFE?

StockAlpha's latest AI research report on Pfizer Inc. (PFE), "PFE Stock: Earnings, Yield and Patent Risks", was published on November 14, 2026 and rates the overall sentiment as neutral. Pfizer beat Q3 estimates and raised its 2026 revenue forecast, yet the shares remain weighed down by declining earnings trends and patent-expiration concerns. Here’s a balanced look at the dividend, valuation, analyst expectations and upcoming risks.

When was the PFE research last updated?

The most recent PFE report was published on November 14, 2026.

What do analysts expect for PFE?

As of November 1, 2026, the analyst consensus on PFE is Hold (1 Strong Buy, 8 Buy, 17 Hold, 1 Sell, 1 Strong Sell). As of November 17, 2026, the analyst price target is $31.50 mean (range $27.00 to $40.00).

Is this PFE research investment advice?

No. StockAlpha.ai research is AI-generated analysis for informational purposes only and is not investment advice. Analyst figures are third-party data. Do your own research before making investment decisions.

Keep exploring